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Abstract
Background: Tuberculosis (TB) kills one child every 5 min. Childhood TB is given low priority in most national
health programmes particularly in TB-endemic areas. TB among children is an indicator of a recent transmission of
the disease in the community. Treatment outcome results serve as a proxy of the quality of treatment provided by
a health care system. In Ethiopia, data on treatment outcomes of childhood TB are limited. The aim of the study
was to determine the treatment outcomes of childhood TB in a hospital setting in Addis Ababa.
Methods: The study was conducted during June to August 2014. The data of 491 children treated for TB in
Zewditu Memorial Hospital during a 5 year (2009–2013) was analysed. TB was diagnosed using standard methods.
Demographic and clinical data including type of TB, TB-HIV co-infection and treatment outcomes were collected
from registry of the TB clinic. Treatment outcome definitions are used according to the World Health Organization.
Results: Of the 491 children, 272(55.4 %) were females, 107(21.8 %) were under 5 year old, 454(92.5 %) of them
were new cases. The types of TB were extra-pulmonary tuberculosis (EPTB) 243(49.5 %) and 248(50.5 %) pulmonary
tuberculosis (PTB). Of the PTB cases, 42(16.9 %) were sputum smear positive. Of the 291 children tested for HIV,
82(28.2 %) were positive. The overall treatment success rate was 420(85.5 %) and the poor treatment outcome was
71(14.5 %). Of the children with poor treatment outcome, 9(1.8 %) died, 3(0.6 %) defaulted from treatment, 2(0.4 %)
were treatment failure and 55(11.2 %) were transferred out. Males and females had similar treatment success rates
of 85.8 % and 85.3 %, respectively. Infants under one year had significantly lower treatment success rate of 72.7 %
compared to those above 1 years of age of 86.5 % (P < 0.001). Treatment success rate ranged from 78.0 to 92.6 %
during the study period. Associated factors for treatment outcome were age above 5 years (AOR = 0.59, 95 % CI: 0.
62–0.97) and seropositive for HIV infection (AOR = 6.66, 95 % CI: 3.07–14.47).
Conclusions: The treatment success rate in this study is 85.5 %. The outcome of treatment varied with age, and
presence of HIV infection. In order to the further improve of treatment success rate, continuous follow up with
frequent support of patients during treatment course and strengthen the recording system are strongly recommend.
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Background
Tuberculosis (TB) remains a major global health problem.
It is the second leading cause of death from an infectious
disease worldwide, after the human immunodeficiency
virus (HIV) [1]. Children account for 6 %–10 % of all TB
cases worldwide [2]. TB kills one child every 5 minutes. In
countries with high burden TB, it may be as high as 20–
40 % of all new TB cases. More than 74,000 children die
from the disease each year [2]. Of the one million esti-
mated cases of TB in children worldwide, 75 % occur in
the 22 high-burden countries [3]. As childhood TB re-
flects ongoing transmission in the community, children
are affected most acutely in areas where adult TB is poorly
controlled [4]. Childhood TB is usually acquired from an
infectious adult contact [5]. The global TB control strategy
has focused predominantly on smear-positive adult cases
and not on the usually paucibacillary and smear negative,
noncontagious, asymptomatic childhood TB [6]. TB among
children is much more prevalent in developing countries
due to poor socio-economic conditions, malnutrition,
over-crowding, HIV co-infection and high prevalence of
TB in adults contacts [7]. Childhood TB remains neglected
for various reasons, mainly the difficulty in diagnosing pul-
monary tuberculosis (PTB), the unknown outcomes of
children with TB, and the belief that childhood TB is not
important for TB control [8, 9]. In 2013, the World Health
Organization (WHO) developed a roadmap aiming to
achieve zero deaths due to childhood TB by 2025 [10].
Treatment outcome results serve as a proxy of the qual-
ity of TB treatment provided by a health care system.
Treatment success measured by treatment outcome moni-
toring (TOM) is a key output of any TB control programs
[11]. Treatment outcome in all patients should be routinely
monitored by the epidemiological surveillance system. This
would make it possible to recognize and amend system
failures before the incidence and proportion of resistant
isolates rise [12]. According to the 2012 WHO report,
Ethiopia ranks seventh among the world’s 22 countries
with a high TB burden [1]. Hospital data show that TB is
the leading cause of morbidity, third cause of hospital ad-
missions after deliveries and malaria, and second cause of
death after malaria in Ethiopia [13]. Although scanty re-
ports on treatment outcomes of TB among adults are
available, little is known in children in from Ethiopia [14].
Therefore, this study aimed to assess prevalence and treat-
ment outcomes of TB among children on treatment follow
up in Zewditu Memorial Hospital, Addis Ababa.
Methods
Study design, study site and period
A 5-year (2009–2013) hospital- based retrospective co-
hort study was done to assess the treatment outcomes of
childhood TB in Zewditu Memorial Hospital in Addis
Ababa. The hospital is one of the six district hospitals
under the Addis Ababa City administration health bur-
eau. It is the largest treatment centre of HIV infection in
the country. The hospital receives children and adults
referred from the city and all over the country for diag-
nosis and treatment. Data for the study was extracted
from registry of TB cases treated under directly observed
treatment- short course (DOTS) strategy during January
1, 2009 to December 31, 2013. The study was conducted
during June to August 2014.
Study population
A total of 491 children diagnosed as having TB of all
types registered during 2009–2013 had follow up in the
TB clinic were included in the study. TB patients with
incomplete data were excluded from the study. All sub-
jects below the age of 15 years with complete sociode-
mographic and clinical data were illegible for the study.
Data collection and diagnostic methods
Data were collected on standardized forms that included
demographics (age, sex), clinical history, laboratory and
radiographic testing, HIV test results, type and category
of TB, treatment outcomes. Diagnosis of TB was made
according to the recommendations of the Ministry of
Health (MoH) of Ethiopia, which was adopted from the
WHO [13]. History of contact with TB patient, signs and
symptoms suggestive of TB were taken. Patients presenting
with cough lasting for more than 2 weeks smear micro-
scopic examination of sputum for bacteriological confirm-
ation was done. Chest x-ray was also taken. Culture for
mycobacteria was done particularly for those suspected to
have multi drug resistant TB. Patients with at least two
positive smears were considered to have smear-positive
pulmonary tuberculosis (SPPTB); those with three negative
smears were treated with antibiotics and then re-evaluated.
Diagnosis of extra pulmonary tuberculosis (EPTB) was
based on fine needle aspiration cytology, biochemical ana-
lyses of cerebrospinal/pleural/ ascetic fluids or histopatho-
logical examination in addition to clinical evidences
consistent with active EPTB. Treatment was based on the
the guidelines of the country with a full course of anti-TB
therapy (DOTs). Treatment of new TB patients consists of
a 2-month intensive phase with Isoniazid, Rifampicin, Pyr-
azinamide and Ethambutol followed by a 4-month con-
tinuation phase with Rifampicin and Isoniazid. Outcomes
were categorized as favorable (cured/success) and unfavor-
able (loss to follow-up, died, failure and transfer out).
Data analysis
Data was entered using Epi-Data version 3.1 and analyzed
using computer software SPSS version 20. Descriptive stat-
istical methods were used to generate frequencies of cat-
egorical variables and univariate and multivariate logistic
regression analysis was used to investigate the effect of
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selected risk factors on the incidence of treatment success.
The univariate (unadjusted) and multivariate (adjusted) lo-
gistic regression analysis were used for odds ratios (ORs)
and 95 % confidence interval (95 % CI) was done to assess
the association between potential risk factors and treat-
ment outcome. P value of 0.05 was used as the cut-off
point for statistical significance.
Ethical issues
Ethical clearance was obtained from Department Ethical
and Review Committee (DERC) of Microbiology, Im-
munology and Parasitology (DMIP), College of Health
Sciences, Addis Ababa University. Consent was obtained
from parents or guardians during examinations in the
TB clinic of the hospital. In order to ensure confidential-
ity, names of study participants were not included in the
data sheet. Information obtained from the data of the
study participants is kept confidential.
Definitions of terms
TB cases were defined according to WHO criteria Table 1.
Results
Sociodemographic and clinical characteristics of children
with tuberculosis
A total of 652 children diagnosed to have TB in Zewditu
Memorial Hospital were included in the study. Of these,
161(24.7 %) were excluded because of incomplete data
Table 1 Definitions of terms for type of TB, Patient category, and Treatment outcome as per NLCP a guidelines adopted from the WHO [13]
Category Definition
Type of TB
Childhood TB A person aged 0 – 14 years old who was diagnosed with TB and treated for TB disease
Smear-positive pulmonary
tuberculosis (SPPTB)
Patient with at least two sputum specimens with sputum positive for acid-fast bacilli (AFB) by microscopy,
or a patient with only one sputum specimen with smear positive for AFB by microscopy and chest
radiographic abnormalities consistent with active pulmonary TB.
Smear-negative pulmonary
tuberculosis (SNPTB)
Patient with symptoms suggestive of TB with at least two sputum specimens which were negative for AFB
by microscopy, and with chest radiographic abnormalities consistent with active PTB (including interstitial
or miliary abnormal images), or a patient with two sets of at least two sputum specimens taken at least
two weeks apart, and which were negative for AFB by microscopy, and radiographic abnormalities consistent
with pulmonary TB and lack of clinical response to one week of broad spectrum antibiotic therapy.
Extra-pulmonary tuberculosis (EPTB) TB of organs other than the lungs, such as lymph nodes, abdomen, genitourinary tract, skin, joints, bones,
meninges, etc.
Patient category:
New case Patient who has never had treatment for TB before or has been on anti-TB treatment for less than four weeks.
Relapse Patient who has been declared cure or treatment completed of any form of TB in the past but who reports
back to the health service and is found to be acid fast bacilli smear positive or culture positive.
Treatment failure Patient who, while on treatment remained smear- positive or become again smear-positive at the end of
the five month or later after commencing treatment.
Transfer in Patient who started treatment in one health facility and transferred to the hospital to continue treatment
and follow up.
Retreatment case Patient who has been treated in the past and include: failure, returned after default, relapse cases, and others,
i.e. patients who were previously treated for TB and declared cured before becoming once again a definite
case of pulmonary TB.
Treatment outcome
Cured Finished treatment with negative bacteriology result at the end of treatment
Completed treatment Finished treatment, but without bacteriology result at the end of treatment
Failure Remaining smear positive at five months despite correct intake of medication
Default to treatment Patients who interrupted their treatment for two consecutive months or more after registration
Died Patients who died from TB during the course of treatment
Transferred out Patients whose treatment results are unknown due to transfer to another health facility
Loss to follow up Patient who did not start treatment or whose treatment was interrupted for two consecutive months or more
Successfully treated A patient who completed treatment and cured
Unsatisfactory treatment outcome Patient who died from TB during the course of treatment, interrupted treatment for two consecutive
months or more after registration, patient remaining smear positive at five months despite correct intake
of medication and patient whose treatment results are unknown due to transfer to another health facility
Unknown No treatment details available (e.g., lost patient notes)
aNTLCP = National TB and Leprosy control programme
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while 491(75.3 %) of the patients treated for different TB
types had were illegible and data were analysed. Of the
491children, 219(44.6 %) were males and 272(55.4 %) fe-
males with age range from zero to14 years (mean age of
9.0 ± 4.5SD). Of the total children, under 1 year old had the
least contribution of 33(6.7 %) of the total. In total, the
under five children comprised of 107(21.8 %). Nearly half,
245(49.9 %) were in the age range of 10–14 years. The
remaining patients with incomplete data were excluded
from the study. Of all the TB cases, 243(49.5 %) were due
to EPTB. Of the PTB cases, 206(83.1 %) were SNPTB and
42(16.9 %) were SPPTB cases. Of the Majority of the chil-
dren, 454(92.5 %) were new cases, while 19(3.9 %) were
transferred in, 5(1.0 %) were retreatment (relapse), 3(0.6 %)
cases were default and 2(0.4 %) cases were treatment fail-
ures. Of the 291 children tested for HIV, 82(28.2 %) of them
were positive thus had TB -HIV co-infection (Table 2).
Treatment outcomes
The treatment outcome of the 491 paediatrics TB patients
assessed showed that the overall successful treatment
(cure rate) was 420(85.5 %). The treatment success in
males was 85.8 % while it was 84.9 % in females (P > 0.05).
There was no significant differences in the treatment suc-
cess of new TB cases compared to relapse cases which
was 85.7 and 60 %, respectively (P = 0.32). The treatment
success of HIV negative children was higher, 93.8 %
compared to children with TB-HIV co-infection who
had cure rate of 70.7 % (P =0.00). Similarly, children
with unknown HIV serostatus had a higher treatment
success of 82.5 % compared to the 70.7 % of the HIV posi-
tive cases (P = 0.00). Children in the age group 5–9 had
higher treatment success of 123(88.5 %) compared to chil-
dren of under 1 year of age 24(72.7 %) (P < 0.05). The
treatment success was higher among patients with EPTB,
(86.8 %) compared to those with PTB (81.0 % for SPPTB
and 85.0 % of SNPTB).
The poor outcome of treatment identified showed that
3(0.6 %) were defaulters from treatment, 9(1.8 %) died,
2(0.4 %) were treatment failure and 55(11.2 %) were
transferred out. The treatment outcome reports were
unknown in 3(0.6 %) cases of the pediatric patients. The
death rate is higher in the age range of 1–4 which was
3/74(4.1 %) followed by age group 10–14 with death rate
of 4/245(1.6 %) (Table 3).
Trend analysis of treatment outcomes in the 5 years
Majority of the study participants, 454(92.8 %) were new
cases. The trend of the treatment outcome showed an
increment in treatment success rate during the study
period ranging from 78.0 % in 2009 to 92.6 % in 2013.
The incidence of the disease slightly decreased across
the years, except in 2010 which showed increment.
In the study, the rate of transfer out varied from
5(5.1 %) in 2009 to 20 (20.0 %) in 2012. Highest death
rate of 4.1 % was observed in 2012 (Table 4).
The proportions of SPPTB was 42 (8.6 %), the highest
being 9.9 % during 2010 (Table 4). The trend of EPTB
cases varied across the study period from (52.0 %) in
2011 to (48.0 %) in 2012. The trend of unsatisfactory
treatment outcomes during the study period (i.e. died,
failed, defaulted and unknown treatment outcome) is
presented in (Fig. 1). The assessment of TB types in the
5 years showed that the percent of EPTB cases ranged
from 48 to 52 % compared to the SPPTB cases which
ranged from 7.1 to 9.9 % and SNPTB cases from 38.8 to
47.9 % (Fig. 2). Treatment success rate consistently in-
creased progressively from 78 % during 2009 to 91.4 %
in 2013. The highest treatment success rate (TSR) of
91.4 % was observed in 2013 compared to TSRs across
the earlier years (Fig. 3).
Treatment outcome and associated factors
There was no significant difference in the treatment out-
comes among male and female patients (P = 0.97). Children







< 1 33 6.7
1 – 4 74 15.1
5 – 9 139 28.3
10 – 14 245 49.9
TB category
Pulmonary (248)
Smear positive 42 16.9
Smear negative 206 83.1












aOther: include loss to follow up
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Table 3 Treatment outcomes, Age, Gender, Type of TB, Patient category and HIV status of children
Characteristics Treatment outcomes
Success No (%) Transfer out No (%) Default No (%) Death No (%) Failure No (%) Missing No (%) Total No (%)
Gender
Male 188 (85.8) 23 (10.5) 2 (0.9) 5 (2.3) 0 (0.0) 1 (0.5) 219 (44.6)
Female 232 (85.3) 32 (11.8) 1 (0.4) 4 (1.5) 2 (0.7) 1 (0.7) 272 (55.4)
Age group
< 1 24 (72.7) 9 (27.3) 0 (0.0) 0 (0.0) 0 (0.0) - 33 (6.7)
1–4 64 (86.5) 7 (9.5) 0 (0.0) 3 (4.1) 0 (0.0) - 74 (15.1)
5–9 123 (88.5) 12 (8.6) 0 (0.0) 2 (1.4) 0 (0.0) 2 (1.4) 139 (28.3)
10–14 209 (85.3) 27 (11.0) 3 (1.2) 4 (1.6) 2 (0.8) - 245 (49.9)
Type of TB
SPPTB 34 (81.0) 4 (9.5) 0 (0.0) 2 (4.8) 1 (2.4) 1 (2.4) 42 (16.9)
SNPTB 175 (85.0) 25 (12.1) 1 (0.5) 3 (1.5) 1 (0.5) 1 (0.5) 206 (83.1)
EPTB 211 (86.8) 26 (10.7) 2 (0.8) 4 (1.6) 0 (0.0) - 243 (49.5)
Category of TB
New 389 (85.7) 48 (10.8) 3 (0.7) 8 (1.8) 2 (0.4) 4 (0.9) 454 (92.5)
Relapse 3 (60.0) 2 (40.0) 0 (0.0) 0 (0.0) 0 (0.0) - 5 (1.0)
Failure 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.4) - 2 (0.4)
Transfer in 15 (78.9) 2 (10.5) 0 (0.0) 0 (0.0) 0 (0.0) 2 (10.5) 19 (3.9)
Others 4 (33.3) 4 (33.3) 0 (0.0) 1 (8.33) 0 (0.0) 2 (18.2) 11 (2.2)
HIV Status
Positive 58 (70.7) 12 (14.6) 12 (14.6) 0 (0.0) 0 (0.0) - 82 (28.2)
Negative 196 (93.8) 12 (5.7) 1 (0.5) 0 (0.0) 0 (0.0) - 209 (71.8)
Unknown 165 (82.5 31 (15.5) 2 (1.0) 0 (0.0) 0 (0.0) - 200 (40.7)
SPPTB Smear positive pulmonary tuberculosis, SNPTB smear negative pulmonary tuberculosis, EPTB extra-pulmonary tuberculosis
Missing: attended follow up irregularly
Table 4 Trends of treatment outcomes and TB types in children in the five year period
Treatment outcome
and type of TB
Time (in years) Total No (%)
2009 No (%) 2010 No (%) 2011 No (%) 2012 No (%) 2013 No (%)
Treatment outcome
Success (cured) 78 (78.0) 86 (85.1) 83 (84.7) 87 (88.8) 87 (92.6) 420 (85.5)
Transferred out 21 (21.0) 11 (10.9) 14 (14.3) 5 (5.1) 4 (5.3) 55 (11.2)
Default 0 (0.0) 2 (2.2) 0 (0.0) 1 (1.0) 0 (0.0) 3 (0.6)
Death 0 (0.0) 1 (1.0) 1 (1.0) 4 (4.1) 3 (3.2) 9 (1.8)
Failure 0 (0.0) 1 (1.0) 0 (0.0) 1 (1.0) 0 (0.0) 2 (0.4)
Unknown 1 (1.0) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 2 (0.6)
Total 100 (20.4) 101 (20.6) 98 (19.9) 98 (19.9) 94 (19.1) 491 (100)
Type of TB
SPPTB 9 (9.0) 10 (9.9) 9 (9.2) 7 (7.1) 7 (7.4) 42 (8.6)
SNPTB 42 (42.0) 41 (40.6) 38 (38.8) 44 (47.9) 41 (43.6) 206 (42.0)
EPTB 49 (49.0) 50 (49.5) 51 (52.0) 47 (48.0) 46 (48.9) 243 (49.5)
SPPTB smear positive pulmonary tuberculosis, SNPTB smear negative pulmonary tuberculosis, EPTB extra-pulmonary tuberculosis
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in the age group 5–9 years had statistically significant
treatment success rate compared to the under 1 year
age children (P = 0.04). On the other hand in multivari-
ate adjusted model, variables like age, HIV status and
pulmonary positive case types have shown significant
association with the treatment success (Table 4). On
multivariate logistic regression, children in the age
group 5–9 years were independently associated with
successful treatment outcomes [AOR = 0.59 (0.62–0.97),
P = 0.04].
On the other hand, patients with SPPTB [AOR= 0.72
(0.53 – 0.92) and those with unknown serostatus [AOR =
0.94 (0.57 – 1.68)] had significantly lower treatment
success rates.
Children who were HIV negative showed higher rate
of treatment success compared to the HIV positive pa-
tients [AOR = 6.66 (3.07–14.47), p =0.00). The associated
factors with TSRs were depicted in Table 5.
Discussion
As childhood TB reflects recent transmission, its burden
provides an accurate measure of the level of TB in a com-
munity [15]. Treatment outcomes of TB in children are
rarely evaluated by most TB programs in sub-Saharan
Africa [16]. In 2007, the WHO has called for more studies
to define the global epidemiology of childhood TB be-
cause the literature remains scant, dominated primarily by
studies from industrialized countries [17]. Under 1 year-
old children had the least involvement in 33 (6.7 %) while
under 5 children constituted 107 (11.4 %) of the total TB
patient population. This is similar to a study in India
reporting 11 % despite the fact that rates of childhood TB
are usually considered the highest among those aged 1–4
years [18]. Under-five children constituted the majority of
childhood TB in previous studies in Africa [19] and
Thailand [20]. The low number of under-1 year children
with TB in this study could be due to missing of cases in
Fig. 1 Trend of death, treatment defaulting, transferred out and unknown treatment outcome of pediatric TBs cases
Fig. 2 Trends of childhood tuberculosis types in the five years period
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investigation because of the diagnostic difficulties. In this
study, older children in the age range of 10–14 years rep-
resented nearly half (49.9 %) of the cases with TB. This
finding is similar to a report by Hailu et al. [14] who re-
ported that 48.4 % of all the children assessed for TB were
in the age range of 10–14 years.
TB was slightly higher in female children with male: fe-
male ratio of 0.8:1 (P > 0.05). This finding is in agreement
with the previous study conducted in India, where high
prevalence of 61.7 % was reported in females than in males
[21]. However, many studies show similar infection rates in
children unlike the predominance in adult males [22].
In the present study, nearly half of the cases, 243
(49.5 %) were due to EPTB, while the remaining 248
(50.5 %) were due to PTB. Of the PTB patients, 42
(16.9 %) had SPPTB and 206 (83.1 %) had SNPTB. The
Fig. 3 Trend of treatment success rate (TSR) of childhood tuberculosis in children treated in Zewditu Memorial hospital
Table 5 Predictors of treatment outcome in Children with TB
Characteristics Treatment outcome Univariate analysis Multivariate analysis
Successful No (%) Unfavorable No (%) COR (95 % CI) P value AOR (95 % CI) P value
Gender
Female 232 (85.3) 40 (15.1) Referent
Male 188 (86.1) 31 (13.9) 0.96 (0.56–1.64) 0.97 0.97 (0.97–1.67) 0.97
Age in years
< 1 24 (72.7) 9 (27.3) Referent
1–4 64 (85.0) 10 (15.0) 0.43 (0.14–1.28) 0.15 0.64 (0.63–1.35) 0.15
5–9 123 (88.5) 16 (11.5) 0.35 (0.13–0.97) 0.05 0.59 (0.62–0.97) 0.04a
10–14 213 (87.1) 32 (12.9) 0.40 (0.16–1.02) 0.07 0.58 (0.56–1.03 0.06
Type of TB
SPPTB 34 (81.0) 8 (19.0) Referent
SNPTB 175 (85.0) 31 (15.0) 0.66 (0.22–2.06) 0.66 0.77 (0.59–2.22) 0.68
EPTB 211 (86.8) 32 (13.2) 0.65 (0.26–1.66) 0.43 0.73 (0.96–1.74) 0.44
Category of TB
New 389 (85.7) 65 (14.3) Referent
Retreatment 3 (60.0) 2 (40.0) 3.99 (0.46–30.03) 0.31 4.1 (0.49–30.31) 0.33
Transfer in 15 (83.1) 4 (16.9) 1.60 (0.43–5.35) 0.60 1.65 (0.49–5.60) 0.63
HIV status
Negative 196 (93.8) 13 (6.2) Referent
Positive 58 (70.7) 24 (29.3) 6.24 (2.83–13.91) P < 0.01 6.66 (3.07–14.47) 0.00a
Unknown 165 (82.5) 35 (17.0) 3.20 (1.57–6.61) P < 0.01 3.44 (1.67–6.96) 0.00a
COR crude odds ratio, AOR adjusted odds ratio a Significant
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detection rate of M. tuberculosis (smear positivity) was
slightly higher than a report by the WHO in which
smear-positive TB in children aged <14 years accounted
for 0.6–3.6 % [4]. However, our finding of SPPTB is
similar with the16.8 % report by Tessema et al. [12].
However, the smear positivity rate is lower than a study
done by Alavi et al. (2015) from Iran who reported a
high rate of smear positive cases of 73 (72.3 %) [23].
In the present study, there was a clear trend of smear
positivity in children with increasing age despite the
overall prevalence EPTB children is higher. Majority of
the children were <10 years old which is in agreement
with previous studies [24]. However, the higher smear
positivity was seen in older children. This could be due
to the fact that young children are unable to produce
sputum and thus have paucibacillary PTB. Thus, they
are more likely to have EPTB than older children. In
TB- endemic areas, the diagnosis of TB in children at
lower age is mostly based on clinical and x-ray examina-
tions. Thus, advanced TB diagnostic tools are critical for
the study to avoid missing of childhood TB cases. Majority
of the study participants, 454 (92.5 %) were new cases.
This shows that the relapse and transferred in cases were
small in number. HIV infection increases the susceptibility
to TB. In this study, the prevalence of TB-HIV co-
infection was 82 (28.2 %). Adejumo et al. [16] from
Nigeria reported a 29 % co-infection and 27 % report from
Thailand [20]. However, it is higher compared to previous
reports of 10.9 % by Beza et al. (2013) from Ethiopia [25].
However, this is lower than a prevalence of 52 % reported
by Fairlie et al. (2011) from South Africa [26].
The proportion of children with successful outcome is
an indicator of the quality of TB case management [27].
In this study, the overall treatment success rate among
all children with TB was 85.5 % which meets the WHO
targeted of 85 % first set by the World Health Assembly
in 1991 [1]. However, this finding was higher than in
previous reports from southern Ethiopia where the treat-
ment success rate was 49 % [28]. The proportions of treat-
ment success were 85.7 % for new and 60 % for relapse
(retreatment) cases for the entire study period (P < 0.05).
Children under 1 year old had worst treatment outcome
of 72.7 %. Similar finding was reported by Adejumo et al.
from Nigeria [16]. Children less than 5 years old had a
lower treatment success compared to those above 5 years
(82.2 % versus 86.5 %, respectively). These are consistent
with a study by Dangisso et al. [29].
Although the outcome of TB treatment in children is
frequently not reported for various reasons some of the
facts include lack of scientific studies, and the belief that
childhood TB is not important factor for TB control [7].
In addition, socioeconomic conditions, malnutrition,
over-crowding and HIV co-infection also contribute for
the lower treatment outcomes [6]. This study found that
the treatment outcome of childhood TB treated under
DOTs program at Zewditu Memorial Hospital was satis-
factory. The relatively higher success rate could be due
to better case management with the availability of free
TB treatment in the study health facilities. In addition,
the low death rate of 1.8 % for all pediatric TB cases is
lower than 5.8 % reported from Southern Ethiopia [8],
10.5 % reported from Botswana [30], 10.9 % from
Tanzania [19] and 17 % from Malawi [31].
This study showed an overall default rate of 0.2 %
among the pediatric TB patients in the study health fa-
cilities in the last 5 years. This is much lower compared
to results from previous studies which showed high de-
fault rate in Ethiopia ranging from 3.8–20 % [32, 33].
Defaulter rate was low compared to a report in rural
areas of South Ethiopia which was 13.9 % [34]. The mor-
tality rate of 1.8 %) in our study consistent with a 3.3 %
result reported by Hailu et al. [14] but lower than the
rate 7.1 % reported by Salarri et al. from Iran [35].
Ethiopia is one of the highly affected countries by the
TB/HIV co-epidemic. The WHO global report of 2008
estimated that in Ethiopia 40 % of TB patients tested for
HIV were positive, while routine data from 2006/7 esti-
mated that 31 % of TB patients were HIV positive [8]. In
the present study, 82 (16.7 %) children had TB/HIV co-
infection. This result is lower than the previous reports
because of the reduced incidence of HIV infection in the
country. Recent studies have reported that co-infection
with HIV, young age, having smear-positive PTB, failing
to convert to smear-negative after 2 months of treatment
and living in a rural area were independent risk factors
for unfavorable treatment outcome [7, 26]. Similarly, in
the current study, co-infection with HIV, and age group
of 5–9 year were risk factors for unfavorable outcome
(Additional file 1). The higher incidence of serious forms
of TB (such as meningitis or miliary TB), the immaturity
of the immune system, delayed diagnosis due to the low
sensitivity of diagnostic techniques and the higher preva-
lence of other adverse conditions such as malnutrition
in young children have been reported as factors contrib-
uting towards poor treatment outcome at this age [5].
Few years back, Graham and his colleagues [36] reported
that Malawian children treated for TB often had insuffi-
cient blood levels of medication, which could be due to
several reasons including inappropriate drug dosage
and lower absorption. Similarly, Young children who
are unable, or unwilling to swallow large number of
tablets each day contributing to poor treatment out-
comes. Thus, child friendly formulations are the most
critical need to treat TB [37].
The limitations of the study include many patients
were excluded from the study due to incomplete re-
cords. Another limitation was the absence of microbio-
logic confirmation in most diagnosed patients.
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Conclusions
TB treatment success rate in the current study has simi-
lar to the first set WHO target of 85 % and is higher
than that reported from other studies in the country and
the region. This relatively higher success rate could be
attributable to better case management with the avail-
ability of treatment in the study area. This study showed
that the outcome of treatment varied with age, sex and
type of TB. In order to further improve the treatment
success rate, continuous follow up with frequent support
of patients during treatment course and strengthen the
recording system are strongly recommended.
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Additional file 1: Childhood TB in Addis Ababa, Data. (XLS 70 kb)
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